What's New at CBER

What's New at CBER You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA) The following links have been updated recently: FDA Publishes Complex Innovative Trial Design Program Case Studies  Today, the FDA published a series of case study examples to educate stakeholders and to promote innovation in the area of Complex Innovative Trial Designs (CID). The CID Pilot Meeting Program, launched in 2018, is designed to advance the use of complex adaptive, Bayesian, and other novel clinical trial designs. The program offers sponsors an opportunity for increased interaction with the FDA to discuss specific considerations for a proposed CID. CBER What's New Posted: 01/20/2022 Patient Engagement & Regenerative Medicine: An FDA CBER Workshop for Patient Advocates

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA